Molecular Targets in Lung Cancer: Study of the Evolution of Biomarkers Associated with Treatment with Tyrosine Kinase Inhibitors—Has NF1 Tumor Suppressor a Key Role in Acquired Resistance?

Molecular Targets in Lung Cancer: Study of the Evolution of Biomarkers Associated with Treatment with Tyrosine Kinase Inhibitors—Has NF1 Tumor Suppressor a Key Role in Acquired Resistance?

The application to clinical practice of liquid biopsy in patients with lung cancer has led to an advance in the diagnosis and monitoring of the disease. Detection of alterations in EGFR genes related to TKI treatment in EGFR-mutated non-small cell lung cancer patients is a routine method in patholog...

Full description

Bibliographic Details
Main Authors: Begoña O. Alen, Lara S. Estévez-Pérez, María Teresa Hermida-Romero, Ana Reguera-Arias, Rosario García-Campelo, Mercedes de la Torre-Bravos, Ángel Concha
Format: Article
Language:English
Published: MDPI AG 2022-07-01
Series:Cancers
Subjects:
lung cancer
EGFR
tyrosine kinase inhibitors
liquid biopsy
NGS
NF1
Online Access:https://www.mdpi.com/2072-6694/14/14/3323

Internet

https://www.mdpi.com/2072-6694/14/14/3323

Similar Items